APA (7th ed.) Citation

Blank, A., Markert, C., Hohmann, N., Carls, A., Mikus, G., Urban, S., & Haefeli, W. E. (2016). First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B. Journal of hepatology, 65(3), . https://doi.org/10.1016/j.jhep.2016.04.013

Chicago Style (17th ed.) Citation

Blank, Antje, Christoph Markert, Nicolas Hohmann, Alexandra Carls, Gerd Mikus, Stephan Urban, and Walter E. Haefeli. "First-in-human Application of the Novel Hepatitis B and Hepatitis D Virus Entry Inhibitor Myrcludex B." Journal of Hepatology 65, no. 3 (2016). https://doi.org/10.1016/j.jhep.2016.04.013.

MLA (9th ed.) Citation

Blank, Antje, et al. "First-in-human Application of the Novel Hepatitis B and Hepatitis D Virus Entry Inhibitor Myrcludex B." Journal of Hepatology, vol. 65, no. 3, 2016, https://doi.org/10.1016/j.jhep.2016.04.013.